Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trialSimon Parlow, Rebecca Mathew, Lisa Robinson et al.|American Heart Journal|2023Cited by 17
Rationale and Design of the Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion Trial (CAPITAL-RAPTOR)Pietro Di Santo, Benjamin Hibbert, Omar Abdel‐Razek et al.|BMJ Open|2023Cited by 2
Utility of a Smartphone Application in Assessing Palmar Circulation Before Radial Artery Harvesting for Coronary Artery Bypass GraftingSimon Parlow, Benjamin Hibbert, Pietro Di Santo et al.|Circulation|2023Cited by 1
Management and Outcomes of Type I and Type II Myocardial Infarction in Cardiogenic ShockCameron Stotts, Benjamin Hibbert, Richard G. Jung et al.|CJC Open|2023Cited by 1
Point-of-Care Ultrasound for the Detection of Vascular Access Site Complications—The ULTRASITCOM StudyPietro Di Santo, Benjamin Hibbert, Omar Abdel‐Razek et al.|Journal of the Society for Cardiovascular Angiography & Interventions|2025Cited by 0